OraSure Technologies Inc. (OSUR)

17.18
0.13 0.76
NASDAQ : Health Technology
Prev Close 17.05
Open 17.05
Day Low/High 16.79 / 17.28
52 Wk Low/High 12.73 / 23.01
Volume 756.15K
Avg Volume 616.00K
Exchange NASDAQ
Shares Outstanding 61.49M
Market Cap 1.06B
EPS 0.50
P/E Ratio 33.67
Div & Yield N.A. (N.A)

Latest News

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

While the world's attention turns to Pennsylvania on February 2 nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1 st for the 2018...

2018 OUTLOOK AND INSIGHTS: Investment Trends And Themes To Be Highlighted At The Emerald Groundhog Day Investment Forum

2018 OUTLOOK AND INSIGHTS: Investment Trends And Themes To Be Highlighted At The Emerald Groundhog Day Investment Forum

Join Emerald Asset Management for the landmark 25 th annual Emerald Groundhog Day Investment Forum on February 1 st in Philadelphia.

OraSure Technologies Announces Management Succession Plan

OraSure Technologies Announces Management Succession Plan

Company Also Increases Revenue Forecast for Q4 2017

OraSure Technologies Reaches Analyst Target Price

OraSure Technologies Reaches Analyst Target Price

In recent trading, shares of OraSure Technologies Inc. have crossed above the average analyst 12-month target price of $18.80, changing hands for $18.86/share.

Short Interest In OraSure Technologies Decreases By 71.2%

Short Interest In OraSure Technologies Decreases By 71.2%

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 4,048,939 share decrease in total short interest for OraSure Technologies Inc. , to 1,638,690, a decrease of 71.19% since 10/31/2017.

Oversold Conditions For OraSure Technologies (OSUR)

Oversold Conditions For OraSure Technologies (OSUR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

OSUR Crosses Above Average Analyst Target

OSUR Crosses Above Average Analyst Target

In recent trading, shares of OraSure Technologies Inc. have crossed above the average analyst 12-month target price of $20.80, changing hands for $21.28/share.

First Week Of December 15th Options Trading For OraSure Technologies (OSUR)

First Week Of December 15th Options Trading For OraSure Technologies (OSUR)

Investors in OraSure Technologies Inc. saw new options begin trading this week, for the December 15th expiration.

OraSure Technologies Earnings Conference Call Invitation

OraSure Technologies Earnings Conference Call Invitation

2017 Third Quarter Earnings Conference Call Wednesday, November 1, 2017, 5:00 p.m. ET

The OSUR Paradox: Analysts Bullish But Forecast -9.21% Fall

The OSUR Paradox: Analysts Bullish But Forecast -9.21% Fall

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with OraSure Technologies Inc. .

The OSUR Paradox: Analysts Bullish But Forecast -9.35% Fall

The OSUR Paradox: Analysts Bullish But Forecast -9.35% Fall

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with OraSure Technologies Inc. .

First Week Of April 2018 Options Trading For OraSure Technologies (OSUR)

First Week Of April 2018 Options Trading For OraSure Technologies (OSUR)

Investors in OraSure Technologies Inc. saw new options begin trading this week, for the April 2018 expiration.

September 15th Options Now Available For OraSure Technologies (OSUR)

September 15th Options Now Available For OraSure Technologies (OSUR)

Investors in OraSure Technologies Inc. saw new options begin trading today, for the September 15th expiration.

OraQuick® HIV Self-Test Selected For Next Phase Of STAR Project For HIV Self-Testing In Africa

OraQuick® HIV Self-Test Selected For Next Phase Of STAR Project For HIV Self-Testing In Africa

~Phase II of STAR Project Expected to Deploy 4 Million Additional HIV Self-Tests~

OraSure Technologies Receives World Health Organization Prequalification Of OraQuick® HIV Self-Test

OraSure Technologies Receives World Health Organization Prequalification Of OraQuick® HIV Self-Test

WHO Prequalification will enable procurement of OraQuick® HIV Self-Test with monies from global public health funding sources

TheStreet Quant Rating: B (Buy)